Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Eur J Hum Genet ; 25(10): 1134-1141, 2017 10.
Article in English | MEDLINE | ID: mdl-28905880

ABSTRACT

Pelizaeus-Merzbacher disease (PMD) is a rare Mendelian disorder characterised by central nervous system hypomyelination. PMD typically manifests in infancy or early childhood and is caused by mutations in proteolipid protein-1 (PLP1). However, variants in several other genes including gap junction protein gamma 2 (GJC2) can also cause a similar phenotype and are referred to PMD-like disease (PMLD). Whole-exome sequencing in two siblings presenting with clinical symptoms of PMD revealed a homozygous variant in the arginyl-tRNA synthetase (RARS) gene: NM_002887.3: c.[5A>G] p.(Asp2Gly). Subsequent screening of a PMD cohort without a genetic diagnosis identified an unrelated individual with novel compound heterozygous variants including a missense variant c.[1367C>T] p.(Ser456Leu) and a de novo deletion c.[1846_1847delTA] p.(Tyr616Leufs*6). Protein levels of RARS and the multi-tRNA synthetase complex into which it assembles were found to be significantly reduced by 80 and 90% by western blotting and Blue native-PAGE respectively using patient fibroblast extracts. As RARS is involved in protein synthesis whereby it attaches arginine to its cognate tRNA, patient cells were studied to determine their ability to proliferate with limiting amounts of this essential amino acid. Patient fibroblasts cultured in medium with limited arginine at 30 °C and 40 °C, showed a significant decrease in fibroblast proliferation (P<0.001) compared to control cells, suggestive of inefficiency of protein synthesis in the patient cells. Our functional studies provide further evidence that RARS is a PMD-causing gene.


Subject(s)
Arginine-tRNA Ligase/genetics , Gene Deletion , Mutation, Missense , Pelizaeus-Merzbacher Disease/genetics , Adolescent , Arginine-tRNA Ligase/metabolism , Cells, Cultured , Child , Exome , Female , Fibroblasts/metabolism , Heterozygote , Homozygote , Humans , Male , Pelizaeus-Merzbacher Disease/diagnosis
2.
Eur J Hum Genet ; 21(4): 367-72, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23032112

ABSTRACT

Genome-wide linkage analysis is an established tool to map inherited diseases. To our knowledge it has not been used in prenatal diagnostics of any genetic disorder. We present a family with a severe recessive mental retardation syndrome, where the mother wished pregnancy termination to avoid delivering another affected child. By genome-wide scanning using the Affymetrix (Santa Clara, CA, USA) 10k chip we were able to establish the disease haplotype. Without knowing the exact genetic defect, we excluded the condition in the fetus. The woman finally gave birth to a healthy baby. We suggest that genome-wide linkage analysis--based on either SNP mapping or full-genome sequencing--is a very useful tool in prenatal diagnostics of diseases.


Subject(s)
Genetic Linkage , Genome, Human , Genome-Wide Association Study , Intellectual Disability/diagnosis , Pedigree , Prenatal Diagnosis/methods , Adolescent , Child , Female , Genes, Recessive , Haplotypes , Humans , Intellectual Disability/genetics , Male , Polymorphism, Single Nucleotide , Pregnancy , Young Adult
3.
Pediatr Transplant ; 15(2): E19-24, 2011 Mar.
Article in English | MEDLINE | ID: mdl-20880091
4.
J Pediatr Hematol Oncol ; 32(4): 274-6, 2010 May.
Article in English | MEDLINE | ID: mdl-20445417

ABSTRACT

The epithelioid hemangioendothelioma (EHE) is a rare low-grade tumor of vascular origin that may arise at any site. However, lung and liver represent the 2 main locations. Symptoms of the pulmonary EHE are usually nonspecific and mild. Distant metastases of PEHE are frequent. However, heart metastases have only been reported in connection with primary EHE of the liver. We describe the case of a 15-year-old girl presenting with an abscess forming pneumonia and severe rhythm disturbances associated with an EHE of the lung. The untypical fulminant clinical course, the surgical interventions, and the involvement of the heart as a life threatening complication, eventually on the basis of cardiac metastases of PEHE, are emphasized.


Subject(s)
Arrhythmias, Cardiac/etiology , Heart Neoplasms/secondary , Hemangioendothelioma, Epithelioid/secondary , Lung Neoplasms/pathology , Pneumonia/etiology , Adolescent , Arrhythmias, Cardiac/pathology , Female , Heart Neoplasms/surgery , Hemangioendothelioma, Epithelioid/surgery , Humans , Lung Neoplasms/surgery , Pneumonia/pathology , Prognosis
5.
Am J Med Genet B Neuropsychiatr Genet ; 150B(2): 226-32, 2009 Mar 05.
Article in English | MEDLINE | ID: mdl-18521858

ABSTRACT

Pelizaeus-Merzbacher-like disease (PMLD) is a heterogeneous disease with primary hypomyelination of the central nervous system. Only the minority of patients have mutations in the coding region of the GJA12 gene encoding gap junction protein alpha 12, a subunit of intercellular channels highly expressed by oligodendrocytes, the myelin forming cells of the central nervous system. No other gene has been found so far to be mutated in PMLD besides GJA12. We therefore extended the mutational screening in the GJA12 gene, searched for alternative first exons-as described in mice-determined the human 5'-end of the gene, screened therein for mutations and analyzed for copy number variations of the GJA12 gene in 14 patients with PMLD. Unlike in mice we did not find alternative first exons but detected a unique 79 bp first exon in human adolescent brain and spinal cord. No mutation in this non-coding region was found in our cohort. Copy number variation of the GJA12 gene was assessed by real-time PCR TaqMan gene expression technology, but neither patient showed an aberrant copy number. These data confirm that GJA12 alterations are a rare cause of PMLD-even after extending the screening for copy number variation and for mutations in the non-coding region of GJA12. Full genome scans in informative families and further screenings of candidate genes are feasible approaches to elucidate the genetic background of the majority of patients with PMLD.


Subject(s)
Connexins/genetics , Exons/genetics , Gene Dosage , Pelizaeus-Merzbacher Disease/genetics , Animals , Brain/metabolism , Connexins/metabolism , DNA Mutational Analysis , Genetic Variation , Humans , Mice , Mutation , Spinal Cord/metabolism
6.
Child Neuropsychol ; 14(4): 323-38, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18568780

ABSTRACT

RATIONALE: To provide a better understanding of cognitive functioning, motor outcome, behavior and quality of life after childhood stroke and to study the relationship between variables expected to influence rehabilitation and outcome (age at stroke, time elapsed since stroke, lateralization, location and size of lesion). METHODS: Children who suffered from stroke between birth and their eighteenth year of life underwent an assessment consisting of cognitive tests (WISC-III, WAIS-R, K-ABC, TAP, Rey-Figure, German Version of the CVLT) and questionnaires (Conner's Scales, KIDSCREEN). RESULTS: Twenty-one patients after stroke in childhood (15 males, mean 11;11 years, SD 4;3, range 6;10-21;2) participated in the study. Mean Intelligence Quotients (IQ) were situated within the normal range (mean Full Scale IQ 96.5, range IQ 79-129). However, significantly more patients showed deficits in various cognitive domains than expected from a healthy population (Performance IQ p = .000; Digit Span p = .000, Arithmetic's p = .007, Divided Attention p = .028, Alertness p = .002). Verbal IQ was significantly better than Performance IQ in 13 of 17 patients, independent of the hemispheric side of lesion. Symptoms of ADHD occurred more often in the patients' sample than in a healthy population (learning difficulties/inattention p = .000; impulsivity/hyperactivity p = .006; psychosomatics p = .006). Certain aspects of quality of life were reduced (autonomy p = .003; parents' relation p = .003; social acceptance p = .037). Three patients had a right-sided hemiparesis, mean values of motor functions of the other patients were slightly impaired (sequential finger movements p = .000, hand alternation p = .001, foot tapping p = .043). In patients without hemiparesis, there was no relation between the lateralization of lesion and motor outcome. Lesion that occurred in the midst of childhood (5-10 years) led to better cognitive outcome than lesion in the very early (0-5 years) or late childhood (10-18 years). Other variables such as presence of seizure, elapsed time since stroke and size of lesion had a small to no impact on prognosis. CONCLUSION: Moderate cognitive and motor deficits, behavioral problems, and impairment in some aspects of quality of life frequently remain after stroke in childhood. Visuospatial functions are more often reduced than verbal functions, independent of the hemispheric side of lesion. This indicates a functional superiority of verbal skills compared to visuospatial skills in the process of recovery after brain injury. Compared to the cognitive outcome following stroke in adults, cognitive sequelae after childhood stroke do indicate neither the lateralization nor the location of the lesion focus. Age at stroke seems to be the only determining factor influencing cognitive outcome.


Subject(s)
Cognition Disorders/etiology , Movement Disorders/etiology , Quality of Life , Stroke/complications , Adolescent , Adult , Age of Onset , Attention Deficit Disorder with Hyperactivity/diagnosis , Attention Deficit Disorder with Hyperactivity/etiology , Child , Cognition Disorders/diagnosis , Female , Functional Laterality/physiology , Humans , Intelligence/physiology , Male , Movement Disorders/diagnosis , Neuropsychological Tests , Stroke Rehabilitation , Time Factors , Wechsler Scales , Young Adult
7.
Pediatrics ; 120(5): e1355-8, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17974728

ABSTRACT

We report the uncommon clinical course of tetanus in a completely immunized 14-year-old boy. His initial symptoms, which included a flaccid paralysis, supported a diagnosis of botulism. Preliminary mouse-test results with combined botulinum antitoxins A, B, and E, obtained from tetanus-immunized horses, backed this diagnosis. The change in his clinical course from paralysis to rigor and the negative, more specific, botulinum mouse test with isolated botulinum antitoxins A, B, and E, obtained from nonvaccinated rabbits, disproved the diagnosis of botulism. Tetanus was suspected despite complete vaccination. The final results of a positive mouse test performed with isolated tetanus antitoxin confirmed the diagnosis. Adequate treatment was begun, and the boy recovered completely.


Subject(s)
Tetanus/blood , Tetanus/diagnosis , Vaccination , Adolescent , Animals , Diagnosis, Differential , Humans , Male , Mice , Nervous System Diseases/blood , Nervous System Diseases/diagnosis , Nervous System Diseases/immunology , Tetanus/immunology , Tetanus Antitoxin/immunology
8.
Am J Med Genet B Neuropsychiatr Genet ; 144B(3): 365-6, 2007 Apr 05.
Article in English | MEDLINE | ID: mdl-17171653

ABSTRACT

The human phenotype with primarily impaired myelination is represented by hypomyelinating leukodystrophies. The most frequent form is Pelizaeus-Merzbacher disease, which is due to alterations in the PLP1 gene encoding the major myelin protein. Another form, Pelizaeus-Merzbacher-like disease, is partly associated with mutations in the GJA12 gene encoding gap junction protein alpha 12, but seems to be heterogeneous. Olig1 and Olig2 are transcription factors in oligodendrocyte development. We postulated that disturbed oligodendroglial maturation could be associated with primary hypomyelination in humans and analyzed the coding sequence of OLIG1 and OLIG2 in 13 patients from 12 unrelated families which were thoroughly characterized with regard to phenotype and magnetic resonance imaging results. From our findings we conclude that mutations in OLIG1 and OLIG2 are not likely to be associated with this subgroup of hypomyelinating disorders.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/genetics , Nerve Tissue Proteins/genetics , Pelizaeus-Merzbacher Disease/genetics , Phenotype , Family , Genetic Linkage , Humans , Infant , Membrane Proteins/genetics , Mutation , Myelin Proteolipid Protein/genetics , Oligodendrocyte Transcription Factor 2
9.
Nat Med ; 12(3): 307-9, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16491085

ABSTRACT

We show here that children with pyridoxine-dependent seizures (PDS) have mutations in the ALDH7A1 gene, which encodes antiquitin; these mutations abolish the activity of antiquitin as a delta1-piperideine-6-carboxylate (P6C)-alpha-aminoadipic semialdehyde (alpha-AASA) dehydrogenase. The accumulating P6C inactivates pyridoxal 5'-phosphate (PLP) by forming a Knoevenagel condensation product. Measurement of urinary alpha-AASA provides a simple way of confirming the diagnosis of PDS and ALDH7A1 gene analysis provides a means for prenatal diagnosis.


Subject(s)
Aldehyde Dehydrogenase/genetics , Mutation/genetics , Pyridoxine/metabolism , Seizures/genetics , Animals , Bacterial Proteins/metabolism , CHO Cells , Child , Child, Preschool , Cricetinae , Cricetulus , Exons/genetics , Heterozygote , Homozygote , Humans , Oxidoreductases Acting on CH-NH Group Donors/metabolism , Pipecolic Acids/metabolism , Proline/metabolism , Pyridoxal Phosphate/metabolism
11.
Hum Mutat ; 25(1): 98, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15605415

ABSTRACT

Generalized arterial calcification of infancy (GACI), is characterized by calcification of the internal elastic lamina of large and medium-sized arteries and stenosis due to myointimal proliferation. Although survival to adulthood has been reported, most patients die within the first six months of life. Recently, we found mutations of ENPP1 coding for ecto-nucleotide pyrophosphatase/phosphodiesterase 1 to be associated with GACI in 8 of 11 families. In this study, we analyzed ENPP1 in affected individuals of another 12 unrelated families. We identified 11 novel homozygous or compound heterozygous mutations in 10 of the 12 new families. The mutations (1 nonsense, 7 missense, 1 single amino acid deletion, and 2 frame shift mutations) were scattered over the whole coding region with a slightly more condensed distribution within the catalytic and nuclease-like domain as compared to the first survey. In this study, three mutations were found repeatedly in apparently unrelated patients, 7 x c.913C>A (p.Pro305Thr) and c.2662C [corrected]>T (p.Arg888Trp) as well as c.2320C>T (p.Arg774Cys) each twice. However, haplotype analysis suggested a founder effect of British extraction for mutation c.913C>A (p.Pro305Thr). The fact that the two other mutations c.2662C [corrected]>T (p.Arg888Trp) and c.2320C>T (p.Arg774Cys) occurred twice within a single allele also suggests a single founder. This study confirms the role of ENPP1 mutations as the main cause of GACI and adds considerably to the mutational spectrum of ENPP1.


Subject(s)
Arteries , Calcinosis/genetics , Phosphoric Diester Hydrolases/genetics , Pyrophosphatases/genetics , Vascular Diseases/genetics , Adolescent , Child , DNA Mutational Analysis , Humans , Infant , Infant, Newborn , Mutation
12.
Am J Hum Genet ; 75(2): 251-60, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15192806

ABSTRACT

The hypomyelinating leukodystrophies X-linked Pelizaeus-Merzbacher disease (PMD) and Pelizaeus-Merzbacher-like disease (PMLD) are characterized by nystagmus, progressive spasticity, and ataxia. In a consanguineous family with PMLD, we performed a genomewide linkage scan using the GeneChip Mapping EA 10K Array (Affymetrix) and detected a single gene locus on chromosome 1q41-q42. This region harbors the GJA12 gene, which encodes gap junction protein alpha 12 (or connexin 46.6). Gap junction proteins assemble into intercellular channels through which signaling ions and small molecules are exchanged. GJA12 is highly expressed in oligodendrocytes, and, therefore, it serves as an excellent candidate for hypomyelination in PMLD. In three of six families with PMLD, we detected five different GJA12 mutations, including missense, nonsense, and frameshift mutations. We thereby confirm previous assumptions that PMLD is genetically heterogeneous. Although the murine Gja12 ortholog is not expressed in sciatic nerve, we did detect GJA12 transcripts in human sciatic and sural nerve tissue by reverse-transcriptase polymerase chain reaction. These results are in accordance with the electrophysiological finding of reduced motor and sensory nerve conduction velocities in patients with PMLD, which argues for a demyelinating neuropathy. In this study, we demonstrate that GJA12 plays a key role in central myelination and is involved in peripheral myelination in humans.


Subject(s)
Connexins/genetics , Pelizaeus-Merzbacher Disease/genetics , Amino Acid Sequence , Female , Haplotypes , Humans , Male , Molecular Sequence Data , Nervous System/metabolism , Nervous System/physiopathology , Pedigree , Pelizaeus-Merzbacher Disease/metabolism , Pelizaeus-Merzbacher Disease/physiopathology , Protein Structure, Secondary
13.
Hum Genet ; 114(2): 149-56, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14600829

ABSTRACT

While frame-shift mutations are usually found in Duchenne muscular dystrophy (DMD), in-frame mutations are associated with the less severe phenotype of Becker's muscular dystrophy. Exceptions have been reported in both directions suggesting the existence of modifying genes, which might be helpful for innovation of new therapeutic strategies. We report on the very rare case of an intrafamilially different course of DMD, with the younger brother being far less affected than the older one when compared at the same age. In this context, we constructed a subtraction library enriched for transcripts over-expressed in the patient with the milder phenotype. Twelve random clones were sequenced, followed by database analysis. Six of them, casein kinase 1 alpha 1, RAP2B, dynactin 3 light chain, core binding factor beta, myosin light polypeptide 2 and one hypothetical gene, were further analysed by real-time RT-PCR. All these genes were over-expressed 3-20 times in the less affected patient compared with the more severely affected one. Casein kinase 1 and the hypothetical gene showed even a slightly higher expression than the control. Up-regulation of myosin light polypeptide 2, one of the most sensitive markers of muscle fibre regeneration, obviously reflects the milder phenotype. Casein kinase 1, dynactin and core binding factor are supposed to be involved in cell cycle pathways. RAP is a component of the signalling network which controls fundamental cellular processes such as proliferation and differentiation. All four might be interesting candidates for a therapeutic approach to diminish progression of dystrophy in DMD.


Subject(s)
Genetic Markers , Muscle, Skeletal/pathology , Muscular Dystrophy, Duchenne/genetics , Polymorphism, Genetic , RNA, Messenger/genetics , Casein Kinases , Child , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Dynactin Complex , Gene Library , Humans , Male , Microtubule-Associated Proteins/genetics , Microtubule-Associated Proteins/metabolism , Muscular Dystrophy, Duchenne/pathology , Mutation , Myosins/genetics , Myosins/metabolism , Phenotype , Protein Kinases/genetics , Protein Kinases/metabolism , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Subtraction Technique , Transcription Factor AP-2 , Transcription Factors/genetics , Transcription Factors/metabolism , Transcription, Genetic , rap GTP-Binding Proteins/genetics , rap GTP-Binding Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...